Pharma Journalist -

Fresenius Kabi confirmed the availability of Bortezomib for injection  in the United States. Fresenius Kabi Bortezomib for Injection is available as a single dose vial containing 3.5 mg…
Read More...

GSK asserted that it has received approval from the US FDA center for biologics Evaluation and Research thereby hinting at the usage of FLUARIX QUADRIVALENT in persons 6 months and…
Read More...

FDA approved use of Lynparza (olaparib tablets) to include treatment of patients with certain types of  Breast Cancer that have become widespread and whose tumors possess inherited…
Read More...

Gobal open-access biologics technology platform company, Wuxi Biologics declares that Dr. Chiang Syin has been appointed by Wuxi Biologics as its Chief Quality Officer accountable for…
Read More...

Boston Scientific Corporation declared optimistic outcomes from the WHISPER randomized controlled Trial.According to the data presented at the 2018 Annual meeting of the North American …
Read More...

Private cancer drug discovery and development company, Sci- Engi-Medco Solutions Inc. (SEMCO) has secured a Small Business Innovation Research Phase 1 contract from the National Cancer…
Read More...

Clinical Biopharmaceutical Company Rgenix declared the Clinical and pre-Clinical results by research collaborators at Rgenix and Rockefeller University disclosing that Liver-X…
Read More...

Shiseido Company asserted that it has obtained Olivo Laboratories. Olivo is mainly a Polaris partners- based startup advancing the dermatological field through proprietary biomaterials…
Read More...

It is noteworthy that Ligand Pharmaceuticals entered into license agreement with Glenmark Pharmaceuticals to use Ligand's OmniAb platform including Omnichicken, Omnirat, OmniMouse and…
Read More...

Sarah Cannon entitled Johanna C. Bendell, MD, to Chief Development Officer. Her responsibilities encompass developing and expanding physician, site and Pharma relationships across the…
Read More...